Intravenous (IV) Solutions Market

The Global Intravenous (IV) Solution Market is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022. The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer.

Key Finding

The global Intravenous (IV) Solution market and is expected to reach USD 11,511.2 million by 2022
By type, Total Parenteral Nutrition (TPN) holds the largest market share of global Intravenous (IV) Solution market and is expected to reach USD 4,940.0 million in 2016
By nutritional content, amino acid solution holds the largest market share of global Intravenous (IV) Solution market is expected to reach USD 2,385.0 million in 2016
Intravenous (IV) Solutions Market Scenario:

Intravenous (IV) Solution are intended to be administered to the patients which are deficient in nutrients or at the time of serious dehydration. These solutions are given to the patients whose fluid volume or body nutrients falls. Many companies manufactures packaged intravenous fluids or products or compounds which can be mixed with sterile water to prepare a solution for intravenous administration. The market for intravenous solutions is growing swiftly.

Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/2522

Top 10+ Player Detailed Overview For Intravenous (IV) Solutions Market Key Players & Strategies

Some of the key players in this market are: ICU Medical, Inc. (U.S.), B. Braun Melsungen AG (Germany), Fresenius Kabi AG (Germany), Baxter (U.S.), Amanta Healthcare (India), Terumo Medical Corporation (Tokyo), Grifols S.A. (Spain) and others.

Intravenous (IV) Solutions Market Segmentation

Global Intravenous (IV) Solution Market has been segmented on the basis of type which comprises of total parenteral solution, peripheral parenteral solution. On the basis of nutritional content the market is segmented into amino acid solution, carbohydrates, vitamins & minerals, parenteral lipid emulsion and others. On the basis of end user the market is segmented into hospitals & clinics, ambulatory and home care.

Regional Analysis of Intravenous (IV) Solution Market:

The global market for Intravenous (IV) Solution is growing rapidly. The market for Intravenous (IV) Solution is growing with the CAGR of 7.69% during the forecast period from 2016-2022. North America accounts for largest market share in 2015 and is expected to reach USD 4,276.5 million in 2016. This growth is attributed to the factors such as high IV consumption number, high prevalence of chronic diseases.

Asia-Pacific region is the fastest growing market for real time health monitoring devices, which is expected to grow at a CAGR of 8.34% during the forecast period from 2016 to 2022 is due to the emergence of high-quality and better healthcare infrastructure and institutions in this region.

The report for Global Intravenous (IV) Solution Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Ask to our Experts @ https://www.marketresearchfuture.com/enquiry/2522

Major TOC for Intravenous (IV) Solutions Market:

TABLE OF CONTENTS

1 REPORT PROLOGUE

2 INTRODUCTION

2.1 SCOPE OF STUDY

2.2 RESEARCH OBJECTIVE

2.3 ASSUMPTIONS & LIMITATIONS

2.3.1 ASSUMPTIONS

2.3.2 LIMITATIONS

2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

3.1 PRIMARY RESEARCH

3.2 SECONDARY RESEARCH

4 MARKET DYNAMICS

4.1 INTRODUCTION

4.2 DRIVERS

4.2.1 INCREASING PREVALENCE OF THE CHRONIC DISEASES

4.2.2 RISE OF CHOLERA

4.2.3 GROWING ACCEPTANCE OF VITAMIN C INTRAVENOUS FOR COLORECTAL CANCER

4.3 RESTRAINTS

4.3.1 PRESENCE OF STRINGENT GOVERNMENT REGULATIONS

4.4 OPPORTUNITIES

4.4.1 RISING CONTINUOUS DEMAND OF IV SOLUTIONS IN U.S.

4.5 CHALLENGE

4.5.1 INCREASING VITAMIN C INTRAVENOUS THERAPY PRICES

4.6 MEGA TRENDS

4.7 MACROECONOMIC INDICATORS

T.O.C Continued….!

These intravenous solutions are basically given to the patients whose fluid volume or body nutrients decreases. There are a number of things which can cause a drop in fluid volume such as vomiting and diarrhea are a classic example which is why people are encouraged to drink fluids when they are sick to balance the electrolytes present in their body. Another cause is blood loss causes due to lost blood products and they experience a loss in fluid volume. These products are made under very stringent regulations by government to ensure that patients receive the most appropriate care and there should be constant availability of these IV solutions in the hospitals, clinics and even at homes. The market demand for these products is on the rise in the Asia-Pacific region due to rising prevalence of chronic diseases and is expected to increase over the next few years. Since all of these products are available in portable packages it became easy to use them in a home setting as well.

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.